Abeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at HC Wainwright
Abeona Therapeutics (NASDAQ:ABEO – Free Report) had its price objective boosted by HC Wainwright from $15.00 to $20.00 in a report issued on Wednesday, MarketBeat.com reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Abeona Therapeutics’ Q2 2025 earnings at ($0.37) EPS, Q3 2025 earnings […]
Abeona Therapeutics (NASDAQ:ABEO – Free Report) had its price objective boosted by HC Wainwright from $15.00 to $20.00 in a report issued on Wednesday, MarketBeat.com reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Abeona Therapeutics’ Q2 2025 earnings at ($0.37) EPS, Q3 2025 earnings […]
